A week of new drug development highlights

2023-06-13 13:14:57 rix68722912

2022-11-14 14:22

In the field of anti-infective drugs, Jiangxi Jemincare Group and Shanghai Jemincare Pharmaceutical Company discovered new antifungal compounds. In the field of endocrine drugs, Gilead Sciences and LG Chemical have discovered novel KHK inhibitors; In the field of nervous system drugs, Orexia Therapeutics discovers a novel orexin OX-2 receptor agonist; In the field of antitumor drugs, Haisco Pharmaceutical Company, Jiangsu Hengrui Pharmaceutical Company and Shanghai Hengrui Pharmaceutical Company, Xi 'an Xintong Pharmaceutical Research and Development Company, Qilu Regor Therapeutics Company, Shanghai Aryl Pharmaceutical Company and Zhejiang Hisun Pharmaceutical Company, Nerviano Medical Science Company, Hainan New anti-tumor compounds have been reported by Sparkle Therapeutics, Taizhou Yiteng Pharmaceutical and Humanwell Healthcare Group.

Anti-infective drugs:

Jiangxi Jemincare Group and Shanghai Jemincare Pharmaceutical Company discovered novel antifungal compounds

Endocrine drugs:

Gilead Sciences Discovers novel KHK inhibitors


LG Chemical discovers new KHK inhibitor

Nervous system Drugs:

Orexia Therapeutics discovers novel orexin OX-2 receptor agonist


Antitumor drugs:

Haisco Pharmaceuticals discovers novel PRMT5 inhibitors


Jiangsu Hengrui Pharmaceutical Company and Shanghai Hengrui Pharmaceutical Company discovered new tetrahydronaphthalene compounds

Xi 'an Xintong Pharmaceutical Research and Development Company discovered a novel dual inhibitor of BTK and JAK3

Qilu Regor Therapeutics discovers novel CDK2 inhibitors

New STING agonists were discovered by Shanghai Aryl Pharmaceutical Company and Zhejiang Hisun Pharmaceutical Company

Nerviano Medical Sciences discovers novel CDC7 inhibitors

New FGFR2 inhibitors discovered by Sparkle Therapeutics, Hainan

Taizhou Yiteng Pharmaceutical Company discovered a new CDK7 inhibitor

Humanwell Healthcare Group Inc. discovers novel Mat2A inhibitors

Shanghai Aryl Pharmaceutical Company and Zhejiang Hisun Pharmaceutical Company discovered a novel GTPase KRAS inhibitor

(This article uses data from the cortellis database)


Telephone

022-34514546

Company Address

Room 705-707, Building 2, 245 Jiachuan Road, Xuhui District, Shanghai

Timetable

9:00-17:30

电话咨询
邮件咨询